by Ralf Bartl | Mar 12, 2021 | News
Frankfurt am Main; Crailsheim, March 12, 2021. – GFE and LVL Technologies today announced to strengthening their long cooperation for the current sales and support of PCL’s COVID-19 antigen rapid test, whereas both companies combine their specific core competences to...
by Ralf Bartl | Mar 9, 2021 | News
Frankfurt am Main, March 12, 2021. – GFE announced the CE-IVD approval of its PoET HIV blood screening NAT test. The PCR kit is used on GFE’s new, fully integrated NAT testing solution, the PoET System. With this NAT test GFE continues its tradition as a leading...
by Ralf Bartl | Jan 27, 2021 | News
Frankfurt am Main, January 22, 2021. – GFE today announced the CE-IVD approval of its PoET HCV blood screening NAT test. The PCR kit is used on GFE’s new, fully integrated NAT testing solution, the PoET System. With this NAT test GFE continues its tradition as a...
by Ralf Bartl | Nov 30, 2020 | News
Seoul; Frankfurt am Main, 30. November 2020. – PCL Inc., and GFE today announced their cooperation to promote PCL’s CE-IVD certified “[COV04S] PCL COVID19 Ag Gold Saliva” rapid test in major parts of Europe. This antigen quick test facilitates the sample collection by...
by Ralf Bartl | Nov 23, 2020 | News
Frankfurt am Main, 23. November 2020. – GFE today announced the CE-IVD approval of its PoET HBV Kit for use with the new, fully integrated NAT testing solution, the PoET System. With this kit GFE pursues its tradition as a leading supplier of high-quality blood...